Sellas Life Sciences Group Inc. (RXK3)
Market Closed
17 Jul, 20:00
XFRA 
€
10. 30
-0.8
-7.2072%
€
- Market Cap
- P/E Ratio
- Div Yield
2,200 Volume
-0.87 Eps
€ 11.1
Previous Close Want to track RXK3 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
RXK3 Earnings Reports FAQ
What is the earnings per share (EPS) for RXK3?
The current EPS is -0.87.
What is the company's earnings growth rate?
Sellas Life Sciences Group Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Sellas Life Sciences Group Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Sellas Life Sciences Group Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RXK3 at this time, as Sellas Life Sciences Group Inc has no recent EPS data to calculate it.
